Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in FATE — Fate Therapeutics Inc

CIK 1692234 Seattle, WA
Back to FATE Full portfolio

Position in FATE

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$285,664
+$273,988 QoQ
Shares Held
105,802
+987.3% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. FATE ranks #175 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in FATE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $285,664 105,802
2026-03-31 $11,676 9,731
2025-12-31 $9,113 9,300
2025-09-30 $36,129 28,676
2025-06-30 $18,548 16,562
2025-03-31 $62,705 79,377
2024-12-31 $148,206 89,823
2024-09-30 $220,044 62,870
2024-06-30 $334,339 101,933
2024-03-31 $809,217 110,248
2023-12-31 $874,215 233,748
2023-09-30 $369,899 174,481
2023-06-30 $892,383 187,476
2023-03-31 $980,911 172,090
2022-12-31 $5,337 529
2022-09-30 $11,854 529
2022-06-30 $13,108 529
2022-03-31 $20,509 529
2021-12-31 $30,951 529
2021-09-30 $31,353 529
2021-06-30 $427,353 4,924
2021-03-31 $3,193,782 38,736
2020-12-31 $5,423,791 59,648
2020-09-30 $2,727,990 68,251
2020-06-30 $2,341,690 68,251
2020-03-31 $2,200,521 99,078